Updated July 28 at 6:28pm
Life Sciences
19 results total, viewing 1 - 10
Alexion Pharmaceuticals Inc. this morning hosted a groundbreaking ceremony for an expansion that is expected to double the size of its plant over the next five years. more
MindImmune Therapeutics Inc. will receive $500,000 in seed funding from Slater Technology Fund to support the drug discovery venture’s launch. more
The University of Massachusetts was granted 62 utility patents in 2015, putting the school at No. 30 on a list of the Top 100 worldwide universities that were granted U.S. patents. more
(Updated, 6:15 p.m.) Ventas Inc., a real estate investment trust with more than 1,300 properties, has announced its intention to purchase substantially all of the assets of Wexford Science & Technology LLC. more
More than $480,000 has been awarded by the Rhode Island Foundation in seed funding for 20 medical research projects. more
Alexion Pharmaceuticals Inc. fell the most in six years after the company’s drug for a rare neuromuscular disease failed to meet its primary goal in a final-stage trial. more
Medical-device companies, under pressure from hospitals and health insurers to keep expenses down, are capitalizing on strong cash flows and the stumbling stock market to beef up cost-controlling technologies that may be critical to maintaining growth. more
A national consultant has advised the I-195 Redevelopment District Commission to create a business innovation district in Providence that is larger than the existing footprint of undeveloped land, and to create an advisory council that would include the perspectives of anchor industries and universities. more
EpiVax Inc., the Rhode Island-based vaccine designer and maker of protein therapeutics, has formed a joint venture with Schroedinger LLC, a leading computational chemistry provider, to design “biosuperior” therapies to treat a range of diseases. more
1 | 2 Next »